Skin manifestations in acromegaly

Clinics in Dermatology

Volumn 24, Issue 4, 2006, Pages 256-259

  Ben Shlomo, Anat ^a   Melmed, Shlomo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; GLUCOSE; GLYCOSAMINOGLYCAN; GROWTH HORMONE; HORMONE RECEPTOR BLOCKING AGENT; NICOTINIC ACID; PROTEINASE INHIBITOR; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN; SOMATOMEDIN 1; SOMATOSTATIN; UNCLASSIFIED DRUG;

ACANTHOSIS NIGRICANS; ACROMEGALY; AMENORRHEA; ARTICLE; BONE GROWTH; CARPAL TUNNEL SYNDROME; CLINICAL FEATURE; COLON POLYP; EARLY DIAGNOSIS; FACE EDEMA; FIBROMA; FOOT EDEMA; HAND EDEMA; HEADACHE; HEART DISEASE; HORMONE RELEASE; HUMAN; HYPERHIDROSIS; HYPERPROLACTINEMIA; HYPERTRICHOSIS; HYPERTROPHY; HYPOGONADISM; HYPOPITUITARISM; MALOCCLUSION; METABOLIC DISORDER; MORBIDITY; MORPHOLOGY; MUSCLE CRAMP; MYALGIA; MYOPATHY; NASAL BONE; OILY SKIN; OSTEOARTHROPATHY; PARESTHESIA; PRIORITY JOURNAL; PROGNATHIA; PROTEIN SECRETION; PSORIASIS; REMISSION; SKELETON MALFORMATION; SKIN; SKIN CAPILLARY; SKIN CELL; SKIN MANIFESTATION; SOFT TISSUE; TISSUE GROWTH; TOOTH DISEASE; VASOCONSTRICTION; VISUAL IMPAIRMENT;

ACROMEGALY; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; SKIN DISEASES;

EID: 33745636523     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2006.04.011     Document Type: Article

References (35)

1. Melmed S., and Kleinberg D. Anterior pituitary. In: Larsen P.R., Kronenberg H.M., Melmed S., and Polonsky K.S. (Eds). Williams textbook of endocrinology. 10th ed. (2003), Saunders, Philadelphia (Pa) 177-279
2. Parkinson C., Drake W.M., Wieringa G., et al. Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegaly. Clin Endocrinol (Oxf) 56 (2002) 303-311
3. Fairfield W.P., Sesmilo G., Katznelson L., et al. Effects of a growth hormone receptor antagonist on bone markers in acromegaly. Clin Endocrinol (Oxf) 57 (2002) 385-390
4. Molitch M.E. Clinical manifestations of acromegaly. Endocrinol Metab Clin North Am 21 (1992) 597-614
5. Tavakkol A., Elder J.T., Griffiths C.E., et al. Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol 99 (1992) 343-349
6. Lobie P.E., Breipohl W., Lincoln D.T., et al. Localization of the growth hormone receptor/binding protein in skin. J Endocrinol 126 (1990) 467-471
7. Oakes S.R., Haynes K.M., Waters M.J., et al. Demonstration and localization of growth hormone receptor in human skin and skin fibroblasts. J Clin Endocrinol Metab 75 (1992) 1368-1373
8. Deplewski D., and Rosenfield R.L. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 140 (1999) 4089-4094
9. Matsuoka L.Y., Wortsman J., Kupchella C.E., et al. Histochemical characterization of the cutaneous involvement of acromegaly. Arch Intern Med 142 (1982) 1820-1823
10. Lange M., Thulesen J., Feldt-Rasmussen U., et al. Skin morphological changes in growth hormone deficiency and acromegaly. Eur J Endocrinol 145 (2001) 147-153
11. Braham C., Betea D., Pierard-Franchimont C., et al. Skin tensile properties in patients treated for acromegaly. Dermatology 204 (2002) 325-329
12. Nabarro J.D. Acromegaly. Clin Endocrinol (Oxf) 26 (1987) 481-512
13. Jadresic A., Banks L.M., Child D.F., et al. The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. Q J Med 51 (1982) 189-204
14. Centurion S.A., and Schwartz R.A. Cutaneous signs of acromegaly. Int J Dermatol 41 (2002) 631-634
15. Hofeldt F.D., Levin S.R., Schneider V., et al. Clinical features of acromegaly and response to cryohypophysectomy. Rocky Mt Med J 70 (1973) 21-24
16. Tyrrell J.B., and Wilson C.B. Pituitary syndromes. In: Friesen S.R. (Ed). Surgical endocrinology clinical syndromes (1978), J.B. Lippincott, Philadelphia 304-324
17. Letter: skin tags in diabetes mellitus. N Engl J Med 295 (1976) 172-173
18. Tompkins R.R. Skin tags and diabetes. Arch Dermatol 113 (1977) 1463
19. Crook M.A. Skin tags and the atherogenic lipid profile. J Clin Pathol 53 (2000) 873-874
20. Bhansali A., Kochhar R., Chawla Y.K., et al. Prevalence of colonic polyps is not increased in patients with acromegaly: analysis of 60 patients from India. J Gastroenterol Hepatol 19 (2004) 266-269
21. Leavitt J., Klein I., Kendricks F., et al. Skin tags: a cutaneous marker for colonic polyps. Ann Intern Med 98 (1983) 928-930
22. Brendler S.J., Watson R.D., Katon R.M., et al. Skin tags are not a risk factor for colorectal polyps. J Clin Gastroenterol 11 (1989) 299-302
23. Piette A.M., Meduri B., Fritsch J., et al. Do skin tags constitute a marker for colonic polyps? A prospective study of 100 asymptomatic patients and metaanalysis of the literature. Gastroenterology 95 (1988) 1127-1129
24. Stone O.J. Acanthosis nigricans-decreased extracellular matrix viscosity: cancer, obesity, diabetes, corticosteroids, somatotrophin. Med Hypotheses 40 (1993) 154-157
25. Downs A.M., and Kennedy C.T. Somatotrophin-induced acanthosis nigricans. Br J Dermatol 141 (1999) 390-391
26. Stals H., Vercammen C., Peeters C., et al. Acanthosis nigricans caused by nicotinic acid: case report and review of the literature. Dermatology 189 (1994) 203-206
27. Mellor-Pita S., Yebra-Bango M., Alfaro-Martinez J., et al. Acanthosis nigricans: a new manifestation of insulin resistance in patients receiving treatment with protease inhibitors. Clin Infect Dis 34 (2002) 716-717
28. Todd D.J., Eedy D.J., and McMillan J.C. Acromegaly and psoriasis. Clin Exp Dermatol 16 (1991) 222-223
29. Weber G., Klughardt G., Neidhardt M., et al. Treatment of psoriasis with somatostatin. Arch Dermatol Res 272 (1982) 31-36
30. Weber G., Neidhardt M., Frey H., et al. Treatment of psoriasis with bromocriptine. Arch Dermatol Res 271 (1981) 437-439
31. Weber G., Klughardt G., and Neidhardt M. Psoriasis and human growth hormone: aetiology and therapy. Arch Dermatol Res 270 (1981) 361-365
32. Valentino A., Fimiani M., Bilenchi R., et al. Therapy with bromocriptine and behavior of various hormones in psoriasis patients. Boll Soc Ital Biol Sper 60 (1984) 1841-1844
33. Venier A., De Simone C., Forni L., et al. Treatment of severe psoriasis with somatostatin: four years of experience. Arch Dermatol Res 280 Suppl (1988) S51-S54
34. Schiavon F., Maffei P., Martini C., et al. Morphologic study of microcirculation in acromegaly by capillaroscopy. J Clin Endocrinol Metab 84 (1999) 3151-3155
35. Maison P., Demolis P., Young J., et al. Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction. Clin Endocrinol (Oxf) 53 (2000) 445-451